Decrease of plasma levels of MMP-3 was also shown in a case report of diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) associated with RA treated with six courses of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy [21]. Here, MMP3 is linked to diffuse large B-cell lymphoma.